References
- Liang C, Cao JT, Liu Z, et al. Positive RT-PCR test results after consecutively negative results in patients with COVID-19. Infect Dis. 2020;52(7):517–519.
- Chong VH, Chong PL, Metussin D, et al. Conduction abnormalities in hydroxychloroquine add on therapy to lopinavir/ritonavir in COVID-19. J Med Virol. 2020. DOI:10.1002/jmv.26004
- Lan L, Xu D, Ye G, et al. Positive RT-PCR test results in patients recovered from COVID-19. JAMA. 2020;323(15):1502.
- Chen M, An W, Xia F, et al. Clinical characteristics of re-hospitalized patients with COVID-19 in China. J Med Virol. 2020. DOI:10.1002/jmv.26002
- Yang JR, Deng DT, Wu N, et al. Persistent viral RNA positivity during recovery period of a patient with SARS-CoV-2 infection. J Med Virol. 2020. DOI:10.1002/jmv.25940
- Cao H, Ruan L, Liu J, et al. The clinical characteristic of eight patients of COVID-19 with positive RT-PCR test after discharge. J Med Virol. 2020. DOI:10.1002/jmv.26017
- Fu W, Chen Q, Wang T. Letter to the Editor: three cases of re-detectable positive SARS-CoV-2 RNA in recovered COVID-19 patients with antibodies. J Med Virol. 2020. DOI:10.1002/jmv.25968
- European Centre for Disease Prevention and Control (ECDC). Guidance for discharge and ending isolation in the context of widespread community transmission of COVID-19; first update. Technical Report 8th April 2020. [retrieved 2020 May 30]. Available from: https://www.ecdc.europa.eu/en/publications-data/covid-19-guidance-discharge-and-ending-isolation
- Kang YJ. South Korea’s COVID-19 infection status: from the perspective of re-positive after viral clearance by negative testing. Disaster Med Public Health Prep. 2020;1–7. DOI:10.1017/dmp.2020.168